BeOne Medicines AG
BEIGF
$22.50
-$1.25-5.25%
OTC PK
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.74% | 5.84% | |||
| Total Other Revenue | 20.16% | 25.81% | |||
| Total Revenue | 1.02% | 6.08% | |||
| Cost of Revenue | 17.41% | -27.52% | |||
| Gross Profit | -0.70% | 11.51% | |||
| SG&A Expenses | -0.03% | 4.97% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.78% | 5.12% | |||
| Operating Income | 35.06% | 13.44% | |||
| Income Before Tax | 73.69% | 1.41% | |||
| Income Tax Expenses | -61.50% | 270.64% | |||
| Earnings from Continuing Operations | 241.88% | -46.73% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 241.88% | -46.73% | |||
| EBIT | 35.06% | 13.44% | |||
| EBITDA | 31.82% | 10.37% | |||
| EPS Basic | 241.16% | -46.98% | |||
| Normalized Basic EPS | 36.18% | 17.58% | |||
| EPS Diluted | 272.56% | -49.67% | |||
| Normalized Diluted EPS | 36.00% | 17.25% | |||
| Average Basic Shares Outstanding | 0.21% | 0.47% | |||
| Average Diluted Shares Outstanding | 0.34% | 0.75% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||